Psychedelics in Psychiatry: Has Their Time Come?

Strategies in psychedelics in psychiatry.
Guy Goodwin, FMedSci
Format: Microsoft PowerPoint (.ppt)
File Size: 1.44 MB
Released: August 31, 2021

Information on this Educational Activity


Guy Goodwin, FMedSci

Emeritus Professor
Department of Psychiatry
University of Oxford
Oxford, United Kingdom

Guy Goodwin, FMedSci, has disclosed that he has received consulting fees from Beckley Psytech, Clerkenwell Health, Compass Pathways, Evapharma, H Lundbeck, Johnson & Johnson, Lundbeck Institute, Novartis, P1vital Products, Sage, and Servier; has received other financial or material support from P1vital Products; and has ownership interest in and has received salary from Compass Pathways and P1vital Products.

Program Medium

This program has been made available online.


This activity is provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants provided by
Intra-Cellular Therapies
Neurocrine Biosciences

Related Content

Clinical Care Options (CCO) commentary by Thomas L. Schwartz, MD, on choosing the right atypical antipsychotic in bipolar I and bipolar II patients

Thomas L. Schwartz, MD Released: October 15, 2021

Attention deficits in a bipolar patient with a history of cannabis use from Clinical Care Options (CCO)

Joseph F. Goldberg, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit Released: October 7, 2021 Expired: October 6, 2022

Slides from a presentation that educates clinicians on advances in the treatment of tardive dyskinesia (TD)

John M. Kane, MD Released: October 1, 2021

In Neuroscience Research Review (GME Research Review), Dr Gupta provides commentary on the latest research relevant to clinical practice for opioid use disorder, emotional exhaustion & burnout, PTSD among veterans and familiar risk of depression.

Released: September 29, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.